Royal DSM to acquire the flavor and fragrance bio-based intermediates business from Amyris for $150m.

Royal DSM, a global, purpose-led, science-based company, agreed to acquire the flavor and fragrance bio-based intermediates business from Amyris, a firm that produces and distributes chemical products, for $150m. “We are pleased that we can extend the offering to our customers with an additional seven important intermediates that will help our flavor and fragrance and cosmetics customers to improve their sustainability profile. These bio-based ingredients provide them with attractive and sustainable additional alternatives," Gareth Barker, DSM President of Personal Care & Aroma Ingredients.